General Hospital of Beijing PLA Military Region
12
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
8.3%
1 terminated/withdrawn out of 12 trials
83.3%
-3.2% vs industry average
17%
2 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Application of Endoscopic Scissors Cutting ENBD Tube in the Treatment of Malignant Hilar Biliary Strictures
Role: collaborator
The Study of Neuromuscular Exercise Therapy and Patients Self-management Program in Knee Osteoarthritis
Role: collaborator
Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection
Role: collaborator
CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population
Role: collaborator
Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases
Role: collaborator
Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage
Role: collaborator
Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia
Role: collaborator
Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing
Role: collaborator
Risk Factors for Aortic Dissection in the Chinese Patients
Role: lead
Gender-related Differences in Chinese Patients With AAD
Role: lead
Ulinastatin in Inhalation Lung Injury
Role: collaborator
Smoking Cessation Effect of Tea Filter Through Inhibition of Nicotine Receptor
Role: lead
All 12 trials loaded